CN1762376A - Whitening acne-removing cream - Google Patents
Whitening acne-removing cream Download PDFInfo
- Publication number
- CN1762376A CN1762376A CN 200410084053 CN200410084053A CN1762376A CN 1762376 A CN1762376 A CN 1762376A CN 200410084053 CN200410084053 CN 200410084053 CN 200410084053 A CN200410084053 A CN 200410084053A CN 1762376 A CN1762376 A CN 1762376A
- Authority
- CN
- China
- Prior art keywords
- metronidazole
- hydrochloric acid
- emulsifiable paste
- tasuo
- hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a whitening and moisturizing acne-removing cream comprising the following raw materials (by weight percentage): Ketoconazole and Clobetasol propionate cream 20-40%, metronidazole 5-20%, Lincomycin hydrochloride and Lidocaine hydrochloride gel 35-55%, and Malingua hydrochloride 5-20%.
Description
Technical field:
The present invention relates to the medicine of treatment seat skin ulcer.
Background technology:
The seat skin ulcer claims comedo again, is that a kind of the course of disease is chronic by the pilosebaceous unit disease due to the multiple combined factors effect, easily recurrence, and severe patient leaves pigment red seal or recessed scar after more.Though the seat skin ulcer is a kind of common skin disease, in the youth, seat skin ulcer sickness rate is up to 85%.Because the existence of seat skin ulcer makes a lot of beautiful young womans miss the opportunity of a lot of beauties.So the seat skin ulcer is not only a kind of physical disease, also there is certain influence aspects such as its psychology, emotion to the patient.At present the medicine and the method for the treatment of seat skin ulcer are a lot, although all in treatment, there are many problems in each big infirmary, clinic, beauty parlor, effect is all undesirable.Causing the higher reason of relapse rate at present is to treat not thoroughly, lacks the radical cure method.That is to say that the part bacterium of curing the disease still exists.
Summary of the invention:
The purpose of this invention is to provide a kind of thorough radical cure and bring out the medicine for external use of comedo, can suppress the generation of pathogenic bacteria effectively, thereby reach the purpose of treatment comedo.
Technical scheme of the present invention:
A, prescription: (percentage by weight)
Ketone Kang Tasuo emulsifiable paste 20～40%, metronidazole 5～20%
Lincomycin hydrochloride and lidocaine hydrochloride gel 35～55%, hydrochloric acid Malin melon 5～20%.
The b manufacture method:
Get it filled by above-mentioned weight relationships, agent of metronidazole face and the agent of hydrochloric acid woods guanidine powder are mixed equably; Ketone Kang Tasuo emulsifiable paste and lincomycin hydrochloride and lidocaine hydrochloride gel are mixed, stir all back reflections one hour; Then the metronidazole medicine that mixes and hydrochloric acid woods guanidine face are joined in the good emulsifiable paste of reaction and stir together, the back packing gets final product.
Good effect of the present invention:
1, without any side effect, the effect of existing anti-acne has the effect of cosmetics again;
2, use effective percentage of the present invention can reach 95%.
Why the present invention has so good effect, the extraordinary inhibition of pharmacological action of the composition that mainly is among the present invention to be adopted and eliminate the generation of comedo.Belong to antifungal agent as ketoconazole, have antibacterial and bactericidal action dermophyte, yeast, two-way fungus and Mycophytes; But the plain lidocaine gel of woods enzyme is a compound preparation, its mainly main lincomycin hydrochloride and lidocaine hydrochloride of being divided into, he belongs to bacteriostatic antibiotic, aerobic gram positive bacteria such as staphylococcus, Streptococcus, diphtheria corynebacterium, anthrax bacillus etc. there are the high-efficiency antimicrobial activity, the Grain-negative anaerobe is also had good antibacterial activity.
The specific embodiment:
Below in conjunction with embodiments of the invention the present invention is done into explanation.
Get ketone Kang Tasuo emulsifiable paste 300g, metronidazole 120g
Lincomycin hydrochloride and lidocaine hydrochloride gel 450g, hydrochloric acid woods guanidine 130g.Be about to agent of metronidazole powder and the agent of hydrochloric acid woods guanidine powder and mix uniformly, ketone Kang Tasuo emulsifiable paste and lincomycin hydrochloride and lidocaine hydrochloride gel are mixed, back reflection about a hour stirs; Then the metronidazole medicine that mixes and hydrochloric acid woods guanidine powder are joined in the good emulsifiable paste of reflection and stir together, the back packing gets final product.
Effect:
Heavy person one week～10 day can cure.
The lighter can cure in 3～5 days.
Claims (4)
1, a kind of whitening acne-removing cream is characterized in that it is (percentage by weight) made by the raw material of following consumption:
Ketone Kang Tasuo emulsifiable paste 20～40%, metronidazole 5～20%
Lincomycin hydrochloride and lidocaine hydrochloride gel 35～55%, hydrochloric acid Malin melon 5～20%.
2, according to the described whitening acne-removing cream of claim 1, raw material consumption wherein is:
Ketone Kang Tasuo emulsifiable paste 30%, metronidazole 12%
Lincomycin hydrochloride and lidocaine hydrochloride gel 45%, hydrochloric acid Malin melon 13%.
3, a kind of whitening acne-removing cream is characterized in that it is made up of the following step:
A, press the column weight amount and take by weighing:
Ketone Kang Tasuo emulsifiable paste 20～40%, metronidazole 5～20%
Lincomycin hydrochloride and lidocaine hydrochloride gel 35～55%, hydrochloric acid Malin melon 5～20%.
The b manufacture method:
Get it filled by above-mentioned weight relationships, agent of metronidazole face and the agent of hydrochloric acid woods guanidine powder are mixed equably; Ketone Kang Tasuo emulsifiable paste and lincomycin hydrochloride and lidocaine hydrochloride gel are mixed, stir all back reflections one hour; Then the metronidazole medicine that mixes and hydrochloric acid woods guanidine face are joined in the good emulsifiable paste of reaction and stir together, the back packing gets final product.
4, according to the described whitening acne-removing cream of claim 3, raw material consumption wherein is:
Ketone Kang Tasuo emulsifiable paste 30%, metronidazole 12%
Lincomycin hydrochloride and lidocaine hydrochloride gel 45%, hydrochloric acid Malin melon 13%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410084053 CN1762376A (en) | 2004-10-19 | 2004-10-19 | Whitening acne-removing cream |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410084053 CN1762376A (en) | 2004-10-19 | 2004-10-19 | Whitening acne-removing cream |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1762376A true CN1762376A (en) | 2006-04-26 |
Family
ID=36746835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410084053 Pending CN1762376A (en) | 2004-10-19 | 2004-10-19 | Whitening acne-removing cream |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1762376A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103536664A (en) * | 2012-07-13 | 2014-01-29 | 朱晓明 | Acne removing preparation |
| CN104688808A (en) * | 2015-03-31 | 2015-06-10 | 崔小龙 | Acne cream and preparing method thereof |
-
2004
- 2004-10-19 CN CN 200410084053 patent/CN1762376A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103536664A (en) * | 2012-07-13 | 2014-01-29 | 朱晓明 | Acne removing preparation |
| CN104688808A (en) * | 2015-03-31 | 2015-06-10 | 崔小龙 | Acne cream and preparing method thereof |
| CN104688808B (en) * | 2015-03-31 | 2019-01-04 | 崔小龙 | A kind of Whelk-eliminating paste and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1051453C (en) | Compositions of clindamycin and benzoyl peroxide for acne treatment | |
| JP2006519178A5 (en) | ||
| US4942031A (en) | Compositions containing LYCD and other topically active medicinal ingredients | |
| CN103540200B (en) | A kind of anti-mildew is except methanal paint | |
| Zeichner et al. | From probiotic to prebiotic using thermal spring water | |
| CN111568846A (en) | Anti-acne preparation | |
| CN101601750B (en) | Specific beriberi medicament | |
| CN1762376A (en) | Whitening acne-removing cream | |
| CN106109264A (en) | A kind of facial treatment mask with anti-bacteria wet keeping function and preparation method thereof | |
| CN103479661B (en) | Acne removal and freckle removal cosmetology medicine | |
| CN106617102A (en) | Collagen nutrient power and preparation method thereof | |
| KR20130057962A (en) | Compositions for topical administration | |
| KR101448239B1 (en) | Cosmetic composition containing fruit vinegar | |
| CN103555078B (en) | A kind of anti-mildew is except the preparation method of methanal paint | |
| US20200113954A1 (en) | Pharmaceutical and food composition for the treatment of vaginal and intestinal dysbiosis | |
| KR101448222B1 (en) | Cosmetic composition containing fruit vinegar | |
| CN107961242A (en) | The production method of whitening acne-removing cream | |
| Mishra et al. | Topical antibiotics and semisolid dosage forms | |
| Molting et al. | Treatment of impetigo and ecthyma: a comparison of sulconazole with miconazole | |
| JP2003113097A (en) | External preparation including aureobasidium culture solution | |
| CN101199492A (en) | Application of oligomerization xylose and xylito in coating slice coating | |
| Benfield et al. | Imipenem/Cilastatin: A Pharmacoeconomic Appraisal of its Use in Intra—Abdominal Infections | |
| CN1843366A (en) | Burn-treating liquid | |
| CN101623297B (en) | Medicine for treating beriberi | |
| Rupani | Probiotics for healthy skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Bai Changyi Document name: Written notice of preliminary examination of application for patent for invention |
|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |